LBX Pharmacy Chain Crescita futura
Future criteri di controllo 1/6
LBX Pharmacy Chain is forecast to grow earnings and revenue by 19.6% and 13.8% per annum respectively. EPS is expected to grow by 20.4% per annum. Return on equity is forecast to be 14.7% in 3 years.
Informazioni chiave
21.6%
Tasso di crescita degli utili
21.2%
Tasso di crescita dell'EPS
Consumer Retailing crescita degli utili | 42.3% |
Tasso di crescita dei ricavi | 15.2% |
Rendimento futuro del capitale proprio | 14.8% |
Copertura analitica | Good |
Ultimo aggiornamento | 01 Nov 2024 |
Aggiornamenti recenti sulla crescita futura
Recent updates
LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Price Is Right But Growth Is Lacking After Shares Rocket 30%
Sep 06Is LBX Pharmacy Chain (SHSE:603883) Using Too Much Debt?
Sep 02Take Care Before Jumping Onto LBX Pharmacy Chain Joint Stock Company (SHSE:603883) Even Though It's 30% Cheaper
Jul 03Here's Why We Think LBX Pharmacy Chain (SHSE:603883) Is Well Worth Watching
Jun 08LBX Pharmacy Chain (SHSE:603883) Seems To Use Debt Quite Sensibly
May 21There Is A Reason LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Price Is Undemanding
Apr 22Previsioni di crescita degli utili e dei ricavi
Data | Ricavi | Guadagni | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
---|---|---|---|---|---|
12/31/2026 | 32,160 | 1,412 | 2,584 | 3,247 | 13 |
12/31/2025 | 27,982 | 1,206 | 2,379 | 2,970 | 14 |
12/31/2024 | 22,585 | 841 | 2,532 | 1,991 | 6 |
9/30/2024 | 22,628 | 843 | 1,855 | 2,556 | N/A |
6/30/2024 | 22,566 | 918 | 1,648 | 2,304 | N/A |
3/31/2024 | 22,536 | 959 | 1,741 | 2,298 | N/A |
12/31/2023 | 22,437 | 929 | 2,109 | 2,730 | N/A |
9/30/2023 | 22,441 | 892 | 1,500 | 1,841 | N/A |
6/30/2023 | 21,995 | 842 | 1,990 | 2,337 | N/A |
3/31/2023 | 21,475 | 835 | 2,558 | 2,903 | N/A |
12/31/2022 | 20,176 | 785 | 2,006 | 2,314 | N/A |
9/30/2022 | 18,192 | 746 | 2,201 | 2,530 | N/A |
6/30/2022 | 17,226 | 720 | 1,910 | 2,249 | N/A |
3/31/2022 | 16,198 | 683 | 1,586 | 2,112 | N/A |
12/31/2021 | 15,696 | 669 | 1,820 | 2,298 | N/A |
9/30/2021 | 15,128 | 666 | 1,654 | 2,082 | N/A |
6/30/2021 | 14,741 | 691 | 1,586 | 2,058 | N/A |
3/31/2021 | 14,323 | 653 | 1,362 | 1,693 | N/A |
12/31/2020 | 13,967 | 621 | 1,053 | 1,447 | N/A |
9/30/2020 | 13,413 | 602 | 919 | 1,362 | N/A |
6/30/2020 | 12,816 | 575 | 669 | 1,042 | N/A |
3/31/2020 | 12,218 | 545 | 634 | 1,036 | N/A |
12/31/2019 | 11,663 | 509 | 606 | 1,033 | N/A |
9/30/2019 | 11,069 | 505 | 423 | 1,033 | N/A |
6/30/2019 | 10,567 | 484 | 63 | 990 | N/A |
3/31/2019 | 9,988 | 464 | 1 | 883 | N/A |
12/31/2018 | 9,471 | 435 | 40 | 913 | N/A |
9/30/2018 | 9,015 | 421 | -30 | 559 | N/A |
6/30/2018 | 8,484 | 401 | N/A | 568 | N/A |
3/31/2018 | 7,984 | 388 | N/A | 518 | N/A |
12/31/2017 | 7,501 | 371 | N/A | 498 | N/A |
9/30/2017 | 7,036 | 363 | N/A | 609 | N/A |
6/30/2017 | 6,780 | 343 | N/A | 413 | N/A |
3/31/2017 | 6,494 | 331 | N/A | 420 | N/A |
12/31/2016 | 6,094 | 297 | N/A | 313 | N/A |
9/30/2016 | 5,673 | 285 | N/A | 331 | N/A |
6/30/2016 | 5,250 | 265 | N/A | 280 | N/A |
3/31/2016 | 4,850 | 254 | N/A | 257 | N/A |
12/31/2015 | 4,568 | 241 | N/A | 257 | N/A |
9/30/2015 | 4,331 | 226 | N/A | 217 | N/A |
6/30/2015 | 4,178 | 218 | N/A | 276 | N/A |
3/31/2015 | 4,063 | 212 | N/A | 266 | N/A |
12/31/2014 | 3,943 | 202 | N/A | 247 | N/A |
12/31/2013 | 3,321 | 161 | N/A | 137 | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: 603883's forecast earnings growth (19.6% per year) is above the savings rate (2.9%).
Guadagni vs Mercato: 603883's earnings (19.6% per year) are forecast to grow slower than the CN market (25.8% per year).
Guadagni ad alta crescita: 603883's earnings are forecast to grow, but not significantly.
Ricavi vs Mercato: 603883's revenue (13.8% per year) is forecast to grow slower than the CN market (14% per year).
Ricavi ad alta crescita: 603883's revenue (13.8% per year) is forecast to grow slower than 20% per year.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: 603883's Return on Equity is forecast to be low in 3 years time (14.7%).